The structural basis of PI3K cancer mutations: from mechanism to therapy.

Abstract excerpt

While genetic alteration in the p85α-p110α (PI3K) complex represents one of the most frequent driver mutations in cancer, the wild-type complex is also required for driving cancer progression through mutations in related pathways. Understanding the mechanistic basis of the function of the phosphoinositide 3-kinase (PI3K) is essential for designing optimal therapeutic targeting strategies. Recent structural data...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Enzyme Activation
• Share to Mutation
• Share to Neoplasms